Results 231 to 240 of about 8,514 (288)

Mechanisms underlying allosteric modulation of antiseizure medication binding to synaptic vesicle protein 2A (SV2A). [PDF]

Proc Natl Acad Sci U S A
Mittal A, Martin MF, Provins L, Hall A, Ledecq M, Wolff C, Gillard M, Horanyi PS, Coleman JA.   +8 more
europepmc   +1 more source

Correction to: Antiseizure medication in patients with meningioma: a retrospective cohort study on the long-term impact on depression, anxiety and neurocognitive functioning. [PDF]

J Neurooncol
Laribi L, Scheepens JCC, Zamanipoor Najafabadi AH, Vos MJ, van Furth WR, Peerdeman SM, Taphoorn MJB, Van der Meer PB, Koekkoek JAF, Dutch Meningioma Consortium.   +9 more
europepmc   +1 more source

Patient Perspectives on Antiseizure Medication Discontinuation: A Mixed-Methods Exploration of Risk Perception, Tolerance, and Counseling. [PDF]

Neurol Clin Pract
Terman SW, Silva JM, Kuster M, Lee J, Brand AP, Manuel K, Kalia N, Dugan M, Reid M, Mortati K, Tolmasov A, Patel PS, Burke JF, Grant AC, Hill CE, O'Kula SS.   +15 more
europepmc   +1 more source

Association Between <i>CYP2C9</i> and <i>CYP2C19</i> Genetic Polymorphisms and Antiseizure Medication-Induced Adverse Reactions Among Peruvian Patients with Epilepsy. [PDF]

Pharmaceuticals (Basel)
Alvarado AT, Ignacio-Cconchoy FL, Espinoza-Retuerto JC, Contreras-Macazana RM, Quiñones LA, García JA, Bendezú MR, Chávez H, Surco-Laos F, Laos-Anchante D, Cuba-Garcia PA, Melgar-Merino EJ, Pari-Olarte B, Bonifaz-Hernández M, Almeida-Galindo JS, Kong-Chirinos J, Pariona-Llanos R, Aguilar-Ramírez P, Varela NM.   +18 more
europepmc   +1 more source

Association of maternal epilepsy with perinatal outcomes, and an exploration of prenatal antiseizure medication: A population-based retrospective cohort study. [PDF]

Epilepsia
Mazzone PP, Stephen J, Weir CJ, Bhattacharya S, Black M, Chin RFM.   +5 more
europepmc   +1 more source

Teratogenesis, Perinatal, and Neurodevelopmental Outcomes After In Utero Exposure to Antiseizure Medication. [PDF]

Epilepsy Curr
Pack AM, Oskoui M, Roberson SW, Donley DK, French J, Gerard EE, Gloss D, Miller WR, Clary HMM, Osmundson SS, McFadden B, Parratt K, Pennell PB, Saade G, Smith DB, Sullivan K, Thomas SV, Tomson T, O'Brien MD, Botchway-Doe K, Silsbee HM, Keezer MR.   +21 more
europepmc   +1 more source

Correction for Mittal et al., Mechanisms underlying allosteric modulation of antiseizure medication binding to synaptic vesicle protein 2A (SV2A). [PDF]

Proc Natl Acad Sci U S A
europepmc   +1 more source

Predictive models for starting antiseizure medication withdrawal following epilepsy surgery in adults [PDF]

Brain, 2023
More than half of adults with epilepsy undergoing resective epilepsy surgery achieve long-term seizure freedom and might consider withdrawing antiseizure medications.
Carolina Ferreira-Atuesta, Anna Miserocchi, William P Gray   +2 more
exaly   +3 more sources

Some of the next articles are maybe not open access.

Related searches:

Antiseizure Medications in Pregnancy

Obstetrics and Gynecology Clinics of North America, 2023
Epilepsy affects up to 15 million of people assigned female at birth of childbearing age globally. Up to 65% of these people with epilepsy and gestational capacity have an unplanned pregnancy. Seizure control during pregnancy is important for both the childbearer's and fetus' safety. There are multiple antiseizure medications (ASMs) that can be used to
Alexandra C, Moise, Elizabeth E, Gerard
openaire   +2 more sources

Antiseizure Medications

2022
Abstract The prevalence of epilepsy ranges between 0.6% and 1%, and perhaps 70 million worldwide suffer from this condition. The mainstay of treatment is drug therapy. In the past decade, many new antiseizure medications (ASMs) have been introduced, so that there are now approximately 30 medications available to treat epilepsy.
Ali A. Asadi-Pooya, Michael R. Sperling
openaire   +1 more source